Stat
- Claws of health? Lobster blood could play role in new drugs
- STAT Plus: Biotech founder who said his painkiller would replace opioids sentenced to 7 years in prison
- California governor to address homelessness, mental health
- STAT Plus: European Union proposes independent audits for high-risk AI systems
- STAT Plus: Pharma execs criticize a drug maker over pricing and claim orphan drug law is being misused
NYT science news
- Japan Lets Cruise Passengers Walk Free. Is That Safe?
- Fossil Fuels Are to Blame for Soaring Methane Levels, Study Shows
- To Prevent Next Coronavirus, Stop the Wildlife Trade, Conservationists Say
- Coronavirus Live Updates: Passengers Begin Departing Quarantined Cruise Ship in Japan
- Coronavirus Epidemic Keeps Growing, but Spread in China Slows
Xconomy news
- ResTORbio Pins “Strategic Alternatives” Pitch to Parkinson’s Promise
- Five Prime, Bristol Pancreatic Cancer Drug Combo Fails Phase 2 Test
- Shattuck Labs Promotes Schreiber to CEO, Succeeding Hornblower
- Adaptimmune Taps Abcam’s Gavin Wood for Chief Financial Officer Role
- Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic
Fierce Biotech
- Acutus secures FDA clearance for new real-time heart mapping algorithm
- Gilead poaches Bristol-Myers oncology executive to lead research biology
- Insulet will connect Abbott, Dexcom CGMs with its digital, wearable insulin pump
- Worldwide Clinical Trials boosts exec team with new early-phase lead
- Incyte hits endpoint in 2nd pivotal atopic dermatitis trial
Fierce Medical Devices
- Acutus secures FDA clearance for new real-time heart mapping algorithm
- Insulet will connect Abbott, Dexcom CGMs with its digital, wearable insulin pump
- Baxter probe finds accounting errors leading to $276M in inflated income
- Grail kicks off its first study to provide doctors with real-world results from its multi-cancer blood test
- Coronavirus tests public health infrastructure as providers stockpile equipment